These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

810 related items for PubMed ID: 12436762

  • 21. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug 18; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract] [Full Text] [Related]

  • 22. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D, Kotzka J.
    MMW Fortschr Med; 2007 May 31; 149(22):28-30. PubMed ID: 18069223
    [Abstract] [Full Text] [Related]

  • 23. Genetic determinants of response to statins.
    Peters BJ, Klungel OH, de Boer A, Maitland-van der Zee AH.
    Expert Rev Cardiovasc Ther; 2009 Aug 31; 7(8):977-83. PubMed ID: 19673675
    [Abstract] [Full Text] [Related]

  • 24. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG, Nilsson PM.
    Lakartidningen; 2009 Aug 31; 106(12):854-7. PubMed ID: 19452786
    [No Abstract] [Full Text] [Related]

  • 25. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
    Klose G.
    MMW Fortschr Med; 2005 Dec 08; 147(49-50):20. PubMed ID: 16401005
    [No Abstract] [Full Text] [Related]

  • 26. [When statins alone are not enough. Putting a vice grip on cholesterol].
    MMW Fortschr Med; 2002 Jun 06; 144(23):52-3. PubMed ID: 12119909
    [No Abstract] [Full Text] [Related]

  • 27. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ, Rye KA.
    Circulation; 2006 Sep 19; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
    Weizel A, Sawicki PT.
    MMW Fortschr Med; 2004 Dec 16; 146(51-52):14, 16. PubMed ID: 15675236
    [No Abstract] [Full Text] [Related]

  • 31. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM, Kuller LH.
    Circulation; 2002 Jan 15; 105(2):136-9. PubMed ID: 11790688
    [No Abstract] [Full Text] [Related]

  • 32. [Broader indication for treatment with statins; the 'heart protection study'].
    Cleophas TJ.
    Ned Tijdschr Geneeskd; 2002 Dec 14; 146(50):2453; author reply 2453-4. PubMed ID: 12518529
    [No Abstract] [Full Text] [Related]

  • 33. The case for medical treatment in chronic stable coronary artery disease.
    Nash DT.
    Arch Intern Med; 2002 Dec 14; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414
    [No Abstract] [Full Text] [Related]

  • 34. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].
    Einecke D.
    MMW Fortschr Med; 2004 Mar 25; 146(13):4-5. PubMed ID: 15219114
    [No Abstract] [Full Text] [Related]

  • 35. Focus on HDL as a therapeutic target for CAD risk reduction.
    Davidson MH.
    Am J Cardiol; 2009 Nov 16; 104(10 Suppl):1E-2E. PubMed ID: 19895937
    [No Abstract] [Full Text] [Related]

  • 36. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D.
    Rep Med Guidel Outcomes Res; 2004 Aug 06; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract] [Full Text] [Related]

  • 37. [Statins for cardiovascular prevention. Lowering LDL cholesterol, the primary objective].
    Fruchart JC.
    Presse Med; 2002 Sep 21; 31(30):1428-33. PubMed ID: 12378980
    [Abstract] [Full Text] [Related]

  • 38. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    Arterioscler Thromb Vasc Biol; 2004 Aug 21; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract] [Full Text] [Related]

  • 39. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
    Frolkis JP, Pearce GL, Sprecher DL.
    Am J Cardiol; 2004 Nov 15; 94(10):1310-2. PubMed ID: 15541255
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.